Soterix Medical received CE Mark approval for its transcranial direct current stimulation (tDCS) depression therapy in late December 2015. TDCS Therapy is a non-invasive therapeutic device that delivers low-intensity direct current to a region of the cerebral cortex, the part of the brain that co...
This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!
News Commentary | March 29, 2021
The round was led by Health Catalyst Capital, with previous investors like Novo Nordisk, Insulet, and Mayo Clinic also participating. Glooko has had success in recent years with its diabetes monitoring platform, which connects therapy devices to healthcare providers. The company plans on using the ... Not part of subscription
Case Study | April 20, 2021
In 2020, Biofourmis and Chugai Pharmaceutical partnered to develop an analytics platform for quantifying pain associated with endometriosis. Biofourmis is a global leader in AI‑driven digital therapeutics, and Chugai is a leading Japanese pharmaceutical research company. The platform consists of a ... Not part of subscription
News Commentary | February 07, 2022
Philips' device will be the industry's first attempt at an at‑home, 12‑lead ECG (electrocardiogram). It will include access to Philips' cardiac monitoring portfolio, which pairs cloud‑based data collection with data readings it claims are comparable to clinical ECGs. While the solution is still in ... Not part of subscription